Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

Showing 1-10 of 595

 

USD 3,950.00

USD 2,962.50 save 25 %

05 Nov 1998  |  Global

Opportunities in the Neurogenomics Market

 

 

USD 3,950.00

USD 2,962.50 save 25 %

USD 3,950.00

USD 2,962.50 save 25 %

06 Jun 2001  |  North America

U.S. Pharmacogenomics Markets

 

The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and futu...

USD 3,950.00

USD 2,962.50 save 25 %

04 Oct 2002  |  North America

U.S. Functional Genomics Market

 

Only 2 to 3 percent of the Human Genome sequence contains regulatory information. Knowing how genes are regulated can open a wide field of commercial opportunities, some of which are being persued under the umbrella term of functional genomics. This field spans mutational (wetlab) and expression analysis (microarray) technologies, and is tied toge...

USD 2,450.00

USD 1,837.50 save 25 %

This research service outlines the key advancements in coatings technology for medical devices and drug delivery.

USD 3,950.00

USD 2,962.50 save 25 %

28 Sep 2005  |  Global

Plastics Medical Devices--Emerging Technology and Trends (Technical Insights)

Multi-material Approach to Propel the Need for Adhesives in Body in White (BIW) Structural Applications

This research service outlines the key advancements in plastics technology for medical devices.

USD 3,950.00

USD 2,962.50 save 25 %

This research service analyzes emerging technologies in the field of pharmacogenomics and their impact on the healthcare industry

USD 3,950.00

USD 2,962.50 save 25 %

This strategic analysis service provides a detailed analysis of the European pharmacogenomics market. An indepth analysis of marketing parameters (revenues, forecasts, geographic trends and market share) coupled with competitive factors and strategies for sustained market prevalence are reported.

USD 4,950.00

USD 3,712.50 save 25 %

20 Dec 2006  |  North America

Strategic Analysis of U.S. Genomics Markets

 

This research service provides a strategic analysis of genomics markets within the United States. The market was divided into the total U.S. nucleic acid isolation markets, total U.S. PCR markets, total U.S. qRT-PCR markets, total U.S. DNA microarray markets, and total U.S. DNA sequencing technology markets. Each segment covers market trends, tech...

USD 4,950.00

USD 3,712.50 save 25 %

Showing 1-10 of 595